Publications
Publications
Show Results For
-
All HBS Web
(75)
- Faculty Publications (18)
Page 1 of
18
Results
- January 2020 (Revised July 2020)
- Case
Chemours (A)
By: David G. Fubini and David Lane
The July 2015 spin-off of DuPont’s performance chemicals division as the independent company Chemours burdened new CEO Mark Vergnano and his team with perilous challenges. Despite market-leading offerings in several areas, the company faced a glutted market for its...
View Details
- March 2018
- Teaching Note
Project Titan at Northrop Grumman
By: C. Fritz Foley, Lauren G. Pickle, David Lane and F. Katelynn Boland
Teaching Note for HBS No. 215-001. In March of 2011, Northrop Grumman divested shipbuilding assets through the spin-off of Huntington Ingalls Industries. This case reviews many of the key questions faced by Northrop's CEO, CFO, and top management team during this...
View Details
- January 2018
- Case
Blue Harbour's Activism at Babcock & Wilcox
By: Suraj Srinivasan and Quinn Pitcher
The case describes Blue Harbour Group's investment in Babcock & Wilcox and its transformation into BWX Technologies. In 2004, activist hedge fund Blue Harbour Group invested in Babcock & Wilcox, an energy and construction company. Blue Harbour developed an investment...
View Details
- April 2017 (Revised May 2017)
- Case
GE Capital After the Crisis
By: John C. Coates, John D. Dionne and David S. Scharfstein
Keith Sherin, CEO of GE Capital, faced a decision on which hinged billions of dollars and the fate of one of America’s most storied companies. On his desk sat two secret analyses: Project Beacon, a proposal to spin off most of GE Capital to GE shareholders, and...
View Details
- August 2015 (Revised September 2015)
- Case
Shareholder Activists and Corporate Strategy
By: David Collis and Ashley Hartman
By 2015, there had been an upsurge in activist shareholders arguing for radical changes in companies' corporate strategies. Personalities like Carl Icahn, Bill Ackman, and Daniel Loeb were feared and loathed in some quarters, celebrated in others. With nearly $120...
View Details
Keywords:
Scope;
Activist Investors;
Spin-offs;
Synergy;
Diversification;
Consolidation;
Hedge Fund;
Corporate Strategy
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing;
Licensing Agreements In Biopharmacy;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Partners and Partnerships;
Entrepreneurship;
Growth and Development Strategy;
Biotechnology Industry;
Pharmaceutical Industry;
Netherlands
- February 2015
- Case
Longbow Capital Partners
By: Malcolm Baker, Samuel G. Hanson and James Weber
Longbow Capital Partners is a value-oriented long/short hedge fund focused on stocks in the energy sector. In January 2011, Longbow had invested in NiSource, a Fortune 500 company that owns a diverse portfolio of regulated energy businesses. In late 2014, Longbow was...
View Details
- January 2015 (Revised September 2017)
- Case
Project Titan at Northrop Grumman
By: C. Fritz Foley and Kevin Sharer
In March of 2011, Northrop Grumman divested shipbuilding assets through the spin-off of Huntington Ingalls Industries. This case reviews many of the key questions faced by Northrop's CEO, CFO, and top management team during this process, including questions concerning...
View Details
- October 2014
- Article
Do Analysts Add Value When They Most Can? Evidence from Corporate Spinoffs
By: Emilie Feldman, Stuart C. Gilson and Belen Villalonga
This paper investigates how securities analysts help investors understand the value of diversification. By studying the research that analysts produce about companies that have announced corporate spinoffs, we gain unique insights into how analysts portray diversified...
View Details
- March 2014
- Supplement
School of One: Reimagining How Students Learn (B)
By: John J-H Kim and Christine S. An
This supplements the "A" case. Joel Rose and Chris Rush decide to spin-off from School of One to found New Classrooms Innovation Partners. Rose and Rush navigate the strategic complexities of the spin-off process to make their mission-driven product a reality. The case...
View Details
- November 2012
- Teaching Note
Brink's Company: Activists Push for a Spin-off (TN)
By: Suraj Srinivasan
The case this Teaching Note addresses studies the decision of the security services company Brink's Corporation to spin off its home security division from the rest of the company. The decision followed intense pressure on the company by three activist hedge funds that...
View Details
- November 2011
- Case
Brink's Company: Activists Push for a Spin-off
By: Suraj Srinivasan, Aldo Sesia and Amy Kaser
The case studies the decision of the security services corporation Brink's Company to spin-off its home security division from the rest of the company. The decision followed intense pressure on the company by three activist hedge funds that felt that Brink's was...
View Details
- October 2011 (Revised July 2012)
- Case
Boeing 737 Industrial Footprint: The Wichita Decision
By: Willy Shih and Margaret Pierson
The case examines the circumstances leading up to the Boeing Company's decision to spin-off its Wichita Division. This case is intended to be taught with two other notes: "On the Use of Capital Efficiency Metrics," HBS No. 612-034, "Modularity in Design and...
View Details
- December 2008 (Revised July 2010)
- Case
TravelCenters of America
By: Robin Greenwood, Daniel Jacob Goldberg and James Quinn
A New York-based hedge fund must decide whether to invest in TravelCenters of America (TA), a recent spin-off from a U.S.-based real estate investment trust. The case confronts students with the question: To what extent is this spin-off opportunity attractive from a...
View Details
- January 2006 (Revised May 2007)
- Case
Endo Pharmaceuticals (A): From LBO to...?
By: Richard G. Hamermesh and Brian DeLacey
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company.
View Details
- October 2005
- Case
Tad Piper and Piper Jaffray
By: William W. George and Andrew N. McLean
In 2005, Tad Piper reflects on the successful spin-off from US Bancorp of Piper Jaffray, the investment bank founded by his grandfather. Profiles the development of Piper Jaffray from a Midwestern brokerage house to a national, diversified financial services firm. In...
View Details
- July 2002 (Revised December 2002)
- Case
Mercer Management Consulting (A)
By: Thomas J. DeLong and Michael Echenberg
Insurance giant Marsh & McLennan acquires management consulting firms Temple, Barker & Sloane (TBS) in 1987 and Strategic Planning Associates (SPA) in 1990 and sets out to merge the two. The merger proceeds slowly and painfully. Following the February 1990 merger,...
View Details
- November 1997 (Revised December 2000)
- Case
Corn Products International, Inc.
By: Ray A. Goldberg and Tom Clay
A firm that started in corn processing and moved up the value-added food chain decides to spin-off the original commodity part of the business. How does the new spin-off survive and how does it develop a strategy? Firms in the food system are separating out their...
View Details